StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.78−0.07 (-3.78%)

Close on Nov 17, 2026Market cap $54.27MP/E –Yield –

XBiotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

XBiotech's revenue for the twelve months ending Dec 31, 2023 was $0, down 100.0% year over year. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $44.00M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$4.01M-78.2%
FY2021Dec 31, 2021$18.39M-58.2%
FY2020Dec 31, 2020$44.00M–
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$0-100.0%
Q4 FY2022Dec 31, 2022$300.00K-93.3%
Q3 FY2022Sep 30, 2022$1.68M-62.8%
Q2 FY2022Jun 30, 2022$1.53M-66.2%
Q1 FY2022Mar 31, 2022$500.00K-89.7%
Q4 FY2021Dec 31, 2021$4.50M-14.6%
Q3 FY2021Sep 30, 2021$4.52M-57.2%
Q2 FY2021Jun 30, 2021$4.53M-70.8%
Q1 FY2021Mar 31, 2021$4.85M-61.8%
Q4 FY2020Dec 31, 2020$5.27M–
Q3 FY2020Sep 30, 2020$10.55M–
Q2 FY2020Jun 30, 2020$15.50M–
Q1 FY2020Mar 31, 2020$12.68M–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0–

More XBiotech figures

See a number that looks wrong?